Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.8.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Cash $ 3,027,033 $ 2,886,189
Stock options 2,290,000 0
Depreciation expense $ 10,374 $ 26
Deferred rental income $ 12,769
Useful Life of patents and other technologies 5 years  
Impairment loss $ (1,321,338)
Due to related parties $ 450,000 97,150
Reverse split ratio 1:4  
Beijing GenExosome | Dr. Yu Zhou    
Equity interests ownership percentage 40.00%  
Real property operating [Member]    
Depreciation expense $ 84,814  
PRC [Member]    
Cash 1,327,009 2,525,630
United States [Member]    
Cash $ 1,700,024 $ 360,559